|
ASTE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.526800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.044600E-01 |
| Normal-vs-Stage2 |
4.931600E-01 |
| Normal-vs-Stage3 |
4.496200E-01 |
| Normal-vs-Stage4 |
7.812000E-04 |
| Stage1-vs-Stage2 |
9.797800E-01 |
| Stage1-vs-Stage3 |
9.913600E-01 |
| Stage1-vs-Stage4 |
2.502500E-02 |
| Stage2-vs-Stage3 |
9.888200E-01 |
| Stage2-vs-Stage4 |
1.251440E-01 |
| Stage3-vs-Stage4 |
1.438210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.411950E-01 |
| Normal-vs-AfricanAmerican |
7.754200E-01 |
| Normal-vs-Asian |
9.583000E-01 |
| Caucasian-vs-AfricanAmerican |
4.180800E-01 |
| Caucasian-vs-Asian |
7.426800E-01 |
| AfricanAmerican-vs-Asian |
9.638400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.056400E-02 |
| Normal-vs-Female |
3.702000E-01 |
| Male-vs-Female |
1.897840E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.515600E-01 |
| Normal-vs-Extreme_Weight |
6.086400E-02 |
| Normal-vs-Obese |
1.644550E-01 |
| Normal-vs-Extreme_Obese |
1.342620E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.115400E-01 |
| Normal_Weight-vs-Obese |
8.891600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.116000E-01 |
| Extreme_Weight-vs-Obese |
6.354800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.409200E-01 |
| Obese-vs-Extreme_Obese |
3.332200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.547000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.933200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.730200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.785990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.828600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.079200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.996000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.743600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.748800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.983000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.799000E-01 |
| Normal-VS-Type2 PRCC |
2.520900E-03 |
| Normal-VS-KIRP CIMP |
1.513810E-02 |
| Normal-VS-Unclassified PRCC |
9.623600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.195390E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.232290E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.519400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.199600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.336100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.252400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.220400E-03 |
| Normal-vs-N1 |
7.767400E-01 |
| Normal-vs-N2 |
4.779400E-04 |
| N0-vs-N1 |
6.886000E-02 |
| N0-vs-N2 |
1.485040E-01 |
| N1-vs-N2 |
8.561800E-02 |
|
|
